New eye injection shows promise for blurry vision from corneal swelling
NCT ID NCT06041256
First seen Jan 06, 2026 · Last updated May 16, 2026 · Updated 23 times
Summary
This study tested a single injection called AURN001 in 97 people with corneal swelling (edema) that causes blurry vision. The goal was to see if different doses could safely improve eyesight compared to using the injection's components alone. Participants received one shot, and researchers measured vision changes over six months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORNEAL EDEMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Aurion Biotech site
Little Rock, Arkansas, 72205, United States
-
Aurion Biotech site
Los Angeles, California, 90067, United States
-
Aurion Biotech site
San Francisco, California, 94158, United States
-
Aurion Biotech site
Atlanta, Georgia, 30339, United States
-
Aurion Biotech site
Indianapolis, Indiana, 46260, United States
-
Aurion Biotech site
Wichita, Kansas, 67206, United States
-
Aurion Biotech site
Minnetonka, Minnesota, 55305, United States
-
Aurion Biotech site
Garden City, New York, 11576, United States
-
Aurion Biotech site
Winston-Salem, North Carolina, 27157, United States
-
Aurion Biotech site
Cincinnati, Ohio, 45242, United States
-
Aurion Biotech site
Oklahoma City, Oklahoma, 73104, United States
-
Aurion Biotech site
Bala-Cynwyd, Pennsylvania, 19004, United States
-
Aurion Biotech site
Sioux Falls, South Dakota, 57108, United States
-
Aurion Biotech site
Houston, Texas, 77027, United States
-
Aurion Biotech site
Houston, Texas, 77055, United States
-
Aurion Biotech site
Norfolk, Virginia, 23502, United States
-
Aurion Biotech site
Seattle, Washington, 98125, United States
-
Aurion Biotech site
Vancouver, British Columbia, V5Z 1K1 CAN, Canada
-
Aurion Biotech site
Oakville, Ontario, L6H 0J8 CAN, Canada
-
Aurion Biotech site
Toronto, Ontario, M5T 3A9 CAN, Canada
Conditions
Explore the condition pages connected to this study.